This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both an aminopiperidine and a cyclopentyl group, makes it valuable in the development of drugs targeting the central nervous system (CNS). It is often employed in the creation of compounds with potential therapeutic effects on neurological disorders, such as anxiety, depression, or chronic pain. Additionally, its chemical framework is explored in the design of molecules for cardiovascular and metabolic disease treatments. Researchers also investigate its role in enhancing the bioavailability and efficacy of drug candidates.